Show Me the Data: Immunotherapy Across the Hepatobiliary Cancer Continuum—From Embolization-Eligible HCC to Advanced Biliary Tract Cancers

Starts

November 5, 2026

Ends

November 5, 2026

Format

Online

Location

VIRTUAL